Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.

Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. Clin Infect Dis. 2012 Aug; 55 Suppl 2:S121-6.

View in: PubMed

subject areas

Adult
Aged
Aminoglycosides
Anti-Bacterial Agents
Canada
Candida
Clostridium Infections
Double-Blind Method
Drug Resistance, Bacterial
Enterococcus
Feces
Female
Humans
Incidence
Limit of Detection
Male
Microbial Sensitivity Tests
Middle Aged
Treatment Outcome
United States
Vancomycin

authors with profiles

Kathleen Mullane